This interview is part of a series of articles to mark the 10th anniversary of Cell Death and Differentiation.In the mid-1990s the mitochondrion was found to be part of the central control of the apoptotic process affecting mammalian cells. This discovery has had far-reaching consequences for the comprehension of a variety of human diseases linked to an enhanced apoptotic turnover, such as neurodegeneration, stroke, heart ischemia and AIDS. Moreover, it has become clear that the relative apoptosis resistance of cancer cells may be explained by an alteration of the mitochondrial cell death control. According to the Medline database, more than 7400 papers have now been published on mitochondria and apoptosis. Here, Cell Death and Differentiation asks Guido Kroemer about the early work on mitochondria.
CDD: When did you first hear about apoptosis?Late, when I was beginning to work on peripheral T-cell tolerance in Madrid, in 1989. One mechanism through which autoreactive T lymphocytes are hindered from attacking the immunological self-resides in their physical elimination or 'deletion', and I came across the 'a word' when I read the paper by Wyllie 1 on the oligonucleosomal 'ladder-type' DNA fragmentation of glucocorticoid-treated thymocytes. At that time, back in the 1980s, there was a broad consensus that apoptotic cell death was a nuclear process involving the activation of endonucleases. Chromatin condensation and chromatinolysis were considered as pathognomonic and responsible for apoptosis. So, we treated mice with Staphylococcus aureus enterotoxin B (SEB), a superantigen whose injection can induce T-cell tolerance through activationinduced cell death. 2 We then recovered splenic T cells and investigated whether they had become apoptotic in vivo, after SEB injection. Neither SEB-treated peripheral T cells nor glucocorticoid-treated splenic T cells (that we considered as our internal positive control) did show any sign of chromatin condensation or DNA fragmentation, when analyzed immediately after their isolation from the animal. Only thymocytes did show such changes ex vivo. However, when we cultured Guido Kroemer currently serves as a